| Size | Price | Stock | Qty |
|---|---|---|---|
| 5mg |
|
||
| 10mg |
|
||
| 50mg |
|
||
| Other Sizes |
|
| ln Vitro |
Preferentially, the p110γ and p110δ catalytic domains are inhibited by CAL-130. For p110δ and p110γ, the IC50 values of CAL-130 were 1.3 and 6.1 nM, respectively, whereas for p110α and p110β, they were 115 and 56 nM, respectively. Other intracellular signaling pathways that are essential for overall cellular survival and function, such as p38 MAPK and insulin receptor tyrosine kinase, are not inhibited by CAL-130 [1].
|
|---|---|
| ln Vivo |
Interfering with the combined activities of PI3Kγ and PI3Kδ was found to have therapeutic importance when given to Lck/Ptenfl/fl mice that had T-cell acute lymphoblastic leukemia (T-ALL). The animals considered for survival experiments are not well-groomed, their white blood cell (WBC) counts are higher than 45,000 μL-1, peripheral smears show blast activity, and most circulating cells (>75%) are Thy1.2 and Thy1-sensitive. 2 Positive staining twice. Base-67. Oral CAL-130 (10 mg/kg) was given to mice every 8 hours for 7 days, after which they were monitored until they became moribund. The median survival of treated animals was extended to 45 days by CAL-130, despite the short treatment time, as opposed to 7.5 days for the control group [1].
|
| References |
[1]. Subramaniam Prem S, et al. Targeting nonclassical oncogenes for therapy in T-ALL. Cancer cell (2012), 21(4), 459-72
|
| Molecular Formula |
C23H23CLN8O
|
|---|---|
| Molecular Weight |
462.934722185135
|
| CAS # |
1431697-78-7
|
| Related CAS # |
CAL-130 Racemate;474012-90-3;CAL-130;1431697-74-3
|
| SMILES |
O=C1N(C2=CC=CC=C2C)C([C@H](C)NC3=C4N=CNC4=NC(N)=N3)=NC5=C1C(C)=CC=C5.[H]Cl
|
| HS Tariff Code |
2934.99.9001
|
| Storage |
Powder -20°C 3 years 4°C 2 years In solvent -80°C 6 months -20°C 1 month Note: Please store this product in a sealed and protected environment, avoid exposure to moisture. |
| Shipping Condition |
Room temperature (This product is stable at ambient temperature for a few days during ordinary shipping and time spent in Customs)
|
| Solubility (In Vitro) |
DMSO : ~50 mg/mL (~108.01 mM)
H2O : < 0.1 mg/mL |
|---|---|
| Solubility (In Vivo) |
Solubility in Formulation 1: ≥ 3 mg/mL (6.48 mM) (saturation unknown) in 10% DMSO + 40% PEG300 + 5% Tween80 + 45% Saline (add these co-solvents sequentially from left to right, and one by one), clear solution.
For example, if 1 mL of working solution is to be prepared, you can add 100 μL of 30.0 mg/mL clear DMSO stock solution to 400 μL PEG300 and mix evenly; then add 50 μL Tween-80 to the above solution and mix evenly; then add 450 μL normal saline to adjust the volume to 1 mL. Preparation of saline: Dissolve 0.9 g of sodium chloride in 100 mL ddH₂ O to obtain a clear solution. Solubility in Formulation 2: ≥ 3 mg/mL (6.48 mM) (saturation unknown) in 10% DMSO + 90% (20% SBE-β-CD in Saline) (add these co-solvents sequentially from left to right, and one by one), clear solution. For example, if 1 mL of working solution is to be prepared, you can add 100 μL of 30.0 mg/mL clear DMSO stock solution to 900 μL of 20% SBE-β-CD physiological saline solution and mix evenly. Preparation of 20% SBE-β-CD in Saline (4°C，1 week): Dissolve 2 g SBE-β-CD in 10 mL saline to obtain a clear solution. View More
Solubility in Formulation 3: ≥ 3 mg/mL (6.48 mM) (saturation unknown) in 10% DMSO + 90% Corn Oil (add these co-solvents sequentially from left to right, and one by one), clear solution. |
| Preparing Stock Solutions | 1 mg | 5 mg | 10 mg | |
| 1 mM | 2.1602 mL | 10.8008 mL | 21.6015 mL | |
| 5 mM | 0.4320 mL | 2.1602 mL | 4.3203 mL | |
| 10 mM | 0.2160 mL | 1.0801 mL | 2.1602 mL |
*Note: Please select an appropriate solvent for the preparation of stock solution based on your experiment needs. For most products, DMSO can be used for preparing stock solutions (e.g. 5 mM, 10 mM, or 20 mM concentration); some products with high aqueous solubility may be dissolved in water directly. Solubility information is available at the above Solubility Data section. Once the stock solution is prepared, aliquot it to routine usage volumes and store at -20°C or -80°C. Avoid repeated freeze and thaw cycles.
Calculation results
Working concentration： mg/mL；
Method for preparing DMSO stock solution： mg drug pre-dissolved in μL DMSO (stock solution concentration mg/mL). Please contact us first if the concentration exceeds the DMSO solubility of the batch of drug.
Method for preparing in vivo formulation:：Take μL DMSO stock solution, next add μL PEG300, mix and clarify, next addμL Tween 80, mix and clarify, next add μL ddH2O，mix and clarify.
(1) Please be sure that the solution is clear before the addition of next solvent. Dissolution methods like vortex, ultrasound or warming and heat may be used to aid dissolving.
(2) Be sure to add the solvent(s) in order.
Products are for research use only; We do not sell to patients
Copyright 2020 InvivoChem LLC | All Rights Reserved
